Grants and Contributions:
Title:
Development of new cannabinoid pharmaceuticals
Agreement Number:
890777
Agreement Value:
$160,000.00
Agreement Date:
Jul 3, 2017 - Aug 31, 2019
Description:
Development of improved cannabionoid pharmaceutical products with more convenient routes of administration and/or improved pharmacokinetic profiles.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Nanaimo, British Columbia, CA V9X 1J2
Reference Number:
172-2018-2019-Q3-890777
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
841076631
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 153 days.
Amendment Date
Mar 29, 2019
Recipient's Legal Name:
Tilray Canada, Ltd.
Federal Riding Name:
Nanaimo--Ladysmith
Federal Riding Number:
59018
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
111412
Amendments: